Janssen Announces U.S. FDA Approval of SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive S - PharmiWeb.com

Submitted by Anonymous (not verified) on Mon, 08/03/2020 - 12:11

Janssen Announces U.S. FDA Approval of SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive S  PharmiWeb.com